Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
PLoS One. 2009 Nov 10;4(11):e7766. doi: 10.1371/journal.pone.0007766.
Stimulating naïve CD8+ T cells with specific antigens and costimulatory signals is insufficient to induce optimal clonal expansion and effector functions. In this study, we show that the activation and differentiation of CD8+ T cells require IL-2 provided by activated CD4+ T cells at the initial priming stage within 0-2.5 hours after stimulation. This critical IL-2 signal from CD4+ cells is mediated through the IL-2Rbetagamma of CD8+ cells, which is independent of IL-2Ralpha. The activation of IL-2 signaling advances the restriction point of the cell cycle, and thereby expedites the entry of antigen-stimulated CD8+ T-cell into the S phase. Besides promoting cell proliferation, IL-2 stimulation increases the amount of IFNgamma and granzyme B produced by CD8+ T cells. Furthermore, IL-2 at priming enhances the ability of P14 effector cells generated by antigen activation to eradicate B16.gp33 tumors in vivo. Therefore, our studies demonstrate that a full CD8+ T-cell response is elicited by a critical temporal function of IL-2 released from CD4+ T cells, providing mechanistic insights into the regulation of CD8+ T cell activation and differentiation.
刺激幼稚 CD8+ T 细胞与特定抗原和共刺激信号不足以诱导最佳的克隆扩增和效应功能。在这项研究中,我们表明 CD8+ T 细胞的激活和分化需要在刺激后 0-2.5 小时内的初始启动阶段由激活的 CD4+ T 细胞提供的 IL-2。来自 CD4+细胞的这种关键的 IL-2 信号是通过 CD8+细胞的 IL-2Rbeta gamma 介导的,它独立于 IL-2Ralpha。IL-2 信号的激活推进了细胞周期的限制点,从而加速了抗原刺激的 CD8+T 细胞进入 S 期。除了促进细胞增殖外,IL-2 刺激还增加了 CD8+T 细胞产生的 IFNgamma 和颗粒酶 B 的量。此外,在启动时的 IL-2 增强了由抗原激活产生的 P14 效应细胞在体内消除 B16.gp33 肿瘤的能力。因此,我们的研究表明,由 CD4+ T 细胞释放的 IL-2 的关键时间功能引发了完整的 CD8+ T 细胞反应,为 CD8+ T 细胞激活和分化的调节提供了机制见解。